Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis.
about
Phosphodiesterase 4-targeted treatments for autoimmune diseasesThe synovio-entheseal complex in enthesoarthritis.Tumor necrosis factor inhibitor therapy but not standard therapy is associated with resolution of erosion in the sacroiliac joints of patients with axial spondyloarthritis.Dynamics of syndesmophyte growth in AS as measured by quantitative CT: heterogeneity within and among vertebral disc spacesFat Metaplasia on Sacroiliac Joint Magnetic Resonance Imaging at Baseline Is Associated with Spinal Radiographic Progression in Patients with Axial Spondyloarthritis.High bone turnover assessed by 18F-fluoride PET/CT in the spine and sacroiliac joints of patients with ankylosing spondylitis: comparison with inflammatory lesions detected by whole body MRI.Celastrol inhibits prostaglandin E2-induced proliferation and osteogenic differentiation of fibroblasts isolated from ankylosing spondylitis hip tissues in vitro.Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE studyThe FAt Spondyloarthritis Spine Score (FASSS): development and validation of a new scoring method for the evaluation of fat lesions in the spine of patients with axial spondyloarthritis.A systematic critical review on MRI in spondyloarthritis.MRI and X-ray in axial spondyloarthritis: the relationship between inflammatory and structural changes.Seronegative spondyloarthropathies: what radiologists should know.EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice.Recent Advances in Imaging of the Axial Skeleton in Spondyloarthritis for Diagnosis, Assessment of Treatment Effect, and Prognostication.Mechanism of New Bone Formation in Axial Spondyloarthritis.Baseline increased 18F-fluoride uptake lesions at vertebral corners on positron emission tomography predict new syndesmophyte development in ankylosing spondylitis: a 2-year longitudinal study.Physical activity in axial spondyloarthritis-tails from bench to bedside.Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?Ankylosing spondylitis - the changing role of imaging.Spatial distribution of syndesmophytes along the vertebral rim in ankylosing spondylitis: preferential involvement of the posterolateral rim.Radiographic progression is associated with increased cardiovascular risk in patients with axial spondyloarthritis.MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis.Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort.Different Modulatory Effects of IL-17, IL-22, and IL-23 on Osteoblast Differentiation.Relationship between serum adipokine levels and radiographic progression in patients with ankylosing spondylitis: A preliminary 2-year longitudinal study.Imaging in ankylosing spondylitis.Response to 'Evidence in Support of the Validity of the TNF Brake Hypothesis' by Maksymowych.Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells.Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography.Magnetic resonance imaging in diffuse idiopathic skeletal hyperostosis: similarities to axial spondyloarthritis.Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study.Imbalance Between Bone Morphogenetic Protein 2 and Noggin Induces Abnormal Osteogenic Differentiation of Mesenchymal Stem Cells in Ankylosing Spondylitis.Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by thMCP1 triggers monocyte dysfunctions during abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis.Granulation Tissue Eroding the Subchondral Bone Also Promotes New Bone Formation in Ankylosing Spondylitis.Brief Report: Course of Active Inflammatory and Fatty Lesions in Patients With Early Axial Spondyloarthritis Treated With Infliximab Plus Naproxen as Compared to Naproxen Alone: Results From the Infliximab As First Line Therapy in Patients with Earl[Early therapy of axial spondyloarthritis and relevance of radiological progression].Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.Serum leptin levels are associated with the presence of syndesmophytes in male patients with ankylosing spondylitis.
P2860
Q21245284-FAA1FF6C-815A-43A0-836F-6189177648A8Q33360030-34D34CBD-B50D-4072-8200-22A3622C12ECQ33767110-403F1740-BE6E-44BF-9DF6-469A1EC06551Q35661939-3A67F823-F70B-4D09-BE2C-1F82C962D8A5Q35745265-93AEA222-4BA3-4C69-8E41-FD0344295128Q36320058-13DB70B9-C083-45B6-90AF-39F4ADDF68C7Q36682809-5F2DBBE2-8A93-44D1-BA41-94B0D83317B6Q37539712-A53D7AC3-6A13-46AE-BC32-6321081705CCQ37691058-7332E86C-E115-4D5E-8ADF-11E580DC2615Q37992237-A8130D2E-C5E5-40A6-832C-B097105B0240Q38004583-007D604A-F4CA-4C78-A001-742410BE483AQ38165857-031CDBAB-1001-4A01-8DF9-76A8E6654682Q38402703-9A871F1C-17A3-4E23-A1C7-54115F8F3675Q38561980-2CE92AC0-4592-45C3-9669-C3473685A01CQ38655991-6F3E7718-BEB5-4593-9F0E-51EFBBA0ACE9Q38762450-98405362-D1E8-4CF0-80C3-90FE732B4B04Q38818601-FC217F6D-0ACB-47CB-899F-D287B0BB598EQ38925780-DCFD7444-FAFA-44FC-8EBF-8D1B78890D71Q39598494-90E041C2-A895-414B-879C-42D0D5FC6A62Q40075580-2833FFAA-A9BE-4F2E-9357-7E614E6EDB33Q40324538-6AE28C60-79EA-4149-AFCA-E84B0ABFC3DBQ40436845-4D4C4185-4EA6-433F-8BB3-0062616312F9Q40505103-8CF00840-B638-49C8-9873-31617E1F82C0Q41376059-F850E2F1-0F94-4D84-8459-53C9D5641CDBQ41521787-13415420-683F-4E6D-A3D8-4B20D1A815FFQ41861234-62A15378-1B0C-455D-B35A-BD20677F3683Q44600877-65AE0A4E-FEF7-4622-98BC-8EE0DE157CACQ46412857-DB003E6F-DF7D-4426-92A9-A26F35A30D3EQ47712533-79E610A8-3C07-4F50-9A1E-9054B422EBEDQ48008160-F570D9A6-08BD-46DF-B586-5B458A6EE0B3Q48339869-18752B34-37AD-4C95-808A-6934936B0A57Q48965059-A7D0BCB0-B36A-4BD2-9993-1D17B9C3AF77Q50436452-A2E67E1D-5F57-4D8F-9EA4-8C0B2F923863Q50568498-F21042D0-D74B-40AE-BEF3-14B2127F3F44Q51283796-B4D8ECE3-1F39-493A-BF46-CCE568ED250CQ52853158-2587202F-34BE-4B50-AD01-2AD78D642527Q52854518-8CD2267B-7F07-4690-B8EB-D68D68AFA495Q52889934-740D73DA-D3A3-4C39-81B8-425C468697EEQ53116508-417CD21D-D119-4809-9827-7BAFEA71D09DQ53374383-486940EA-4C1A-4211-A416-DE0396780E8F
P2860
Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Focal fat lesions at vertebral ...... tes in ankylosing spondylitis.
@en
Focal fat lesions at vertebral ...... tes in ankylosing spondylitis.
@nl
type
label
Focal fat lesions at vertebral ...... tes in ankylosing spondylitis.
@en
Focal fat lesions at vertebral ...... tes in ankylosing spondylitis.
@nl
prefLabel
Focal fat lesions at vertebral ...... tes in ankylosing spondylitis.
@en
Focal fat lesions at vertebral ...... tes in ankylosing spondylitis.
@nl
P2860
P356
P1476
Focal fat lesions at vertebral ...... ytes in ankylosing spondylitis
@en
P2093
Barbara Conner-Spady
Praveena Chiowchanwisawakit
P2860
P304
P356
10.1002/ART.30393
P577
2011-08-01T00:00:00Z